Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two Part, Randomized Study of MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers

NCT04647240 is registered in ClinicalTrials.gov with Merakris Therapeutics as lead sponsor.

NCT NCT04647240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04647240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two Part, Randomized Study of MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Lead sponsor
Merakris Therapeutics
Phase
Phase 2
Overall status
Recruiting
Start date
February 26, 2022
Completion date
May 31, 2027
Enrollment
80 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer, venous stasis ulcer